Spectrum Pharmaceuticals, Inc. - Common Stock (NQ:SPPI)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 31, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Spectrum Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Why Clovis Oncology Is Trading Higher By 14%; Here Are 28 Stocks Moving Premarket ↗

September 12, 2022

Gainers Aditxt, Inc. (NASDAQ: ADTX) rose 46.1% to $0.2801 in pre-market trading after jumping 37% on Friday.

Via Benzinga

Spectrum Pharmaceuticals Announces Data from Poster Presentation for Poziotinib in NSCLC Patients with G778_P780dup HER2 Exon 20 Mutations at ESMO Congress 2022

September 10, 2022

From Spectrum Pharmaceuticals, Inc.

Via Business Wire

SPECTRUM PHARMACEUTICALS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Spectrum Pharmaceuticals, Inc. - SPPI

September 09, 2022

From Kahn Swick & Foti, LLC

Via Business Wire

Earnings Scheduled For August 11, 2022 ↗

August 11, 2022

Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million.

Via Benzinga

Important Biotech Catalysts For September 9, 2022 - End Of The Day Summary ↗

September 09, 2022

Via Benzinga

Spectrum Gets FDA Nod For Febrile Neutropenia Candidate, Sees Commercial Launch In Q4 2022 ↗

September 09, 2022

The U.S. Food and Drug Administration (FDA) has approved Spectrum Pharmaceuticals’ (NASDAQ: SPPI) lead asset ROLVEDON (eflapegrastim-xnst) injection to decrease the incidence of infection, as...

Via Benzinga

Spectrum Pharmaceuticals Receives FDA Approval for ROLVEDON™ (eflapegrastim-xnst) Injection

September 09, 2022

From Spectrum Pharmaceuticals, Inc.

Via Business Wire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

September 08, 2022

Good morning! It's time for another overview of the biggest pre-market stock movers as we see what's happening on Thursday!

Via InvestorPlace

Spectrum Pharmaceuticals Announces Poster Presentation for Poziotinib in NSCLC Patients with G778_P780dup HER2 Exon 20 Mutations at the Upcoming ESMO Congress 2022

September 05, 2022

From Spectrum Pharmaceuticals, Inc.

Via Business Wire

Bluebird bio Seeks Back-to-Back Nods, 'Go' or 'No-Go' For Revance's Botox Rival, Amylyx' Twin Hurdles And More: September's Key PDUFA Catalysts Biotech Investors Must Know ↗

August 31, 2022

After August’s mixed tally for Food and Drug Administration approvals, investors turn to a new month, which has a fairly loaded calendar.

Via Benzinga

SPECTRUM PHARMACEUTICALS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Spectrum Pharmaceuticals, Inc. - SPPI

August 12, 2022

From Kahn Swick & Foti, LLC

Via Business Wire

Spectrum Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update

August 11, 2022

From Spectrum Pharmaceuticals, Inc.

Via Business Wire

Spectrum Pharmaceuticals to Report Second Quarter 2022 Financial Results and Provide Corporate Update

July 29, 2022

From Spectrum Pharmaceuticals

Via Business Wire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

June 30, 2022

We're starting off Thursday with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on!

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

June 21, 2022

Gainers

Via Benzinga

Spectrum Pharmaceuticals to Participate in Two Upcoming Investor Conferences

June 02, 2022

From Spectrum Pharmaceuticals, Inc.

Via Business Wire

Spectrum Pharmaceuticals to Present Data at 2022 ASCO Highlighting the Potential Predictive Capabilities of ctDNA as a Biomarker for Poziotinib Treatment Response

May 26, 2022

From Spectrum Pharmaceuticals, Inc.

Via Business Wire

Spectrum Pharmaceuticals to Participate in H.C. Wainwright Global Investment Conference

May 17, 2022

From Spectrum Pharmaceuticals, Inc.

Via Business Wire

Spectrum Pharmaceuticals: Q1 Earnings Insights ↗

May 12, 2022

Spectrum Pharmaceuticals (NASDAQ:SPPI) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Via Benzinga

Spectrum Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update

May 12, 2022

From Spectrum Pharmaceuticals, Inc.

Via Business Wire

The Daily Biotech Pulse: Bristol Myers, BridgeBio Ink Oncology Pact, FDA Nod For Lava Therapeutics Blood Cancer Study And More ↗

May 12, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Spectrum Pharmaceuticals's Earnings Outlook ↗

May 11, 2022

Spectrum Pharmaceuticals (NASDAQ:SPPI) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

Earnings Scheduled For May 12, 2022 ↗

May 12, 2022

Companies Reporting Before The Bell • Chicago Atlantic Real (NASDAQ:REFI) is projected to report earnings for its first quarter.

Via Benzinga

Spectrum Pharmaceuticals Appoints Nora E. Brennan as Chief Financial Officer

May 11, 2022

From Spectrum Pharmaceuticals, Inc.

Via Business Wire

Spectrum Pharmaceuticals to Report First Quarter 2022 Financial Results and Provide Corporate Update

May 06, 2022

From Spectrum Pharmaceuticals

Via Business Wire

Spectrum Pharmaceuticals Appoints Brittany K. Bradrick to Board of Directors

May 05, 2022

From Spectrum Pharmaceuticals

Via Business Wire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

April 21, 2022

Via Benzinga

60 Biggest Movers From Yesterday ↗

April 22, 2022

Gainers Cyngn Inc. (NASDAQ: CYN) shares jumped 96.3% to close at $2.12 on Thursday after the company announced the official launch of DriveMod Kit, a turnkey autonomous vehicle...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

April 11, 2022

Rise and shine, investor! It's time to start off another week of trading with the biggest pre-market stock movers for Monday!

Via InvestorPlace

Spectrum Pharmaceuticals Announces FDA Acceptance of BLA Resubmission for Eflapegrastim

April 11, 2022

From Spectrum Pharmaceuticals, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.